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Summary. Purpose: The aim of this retrospective study was to report the clinical and radiographic results of 
the biodegradable subacromial spacer (InSpace Balloon®) implantation in patients with massive irreparable 
rotator cuff tears. Materials and methods: From February 2014 to October 2015, 30 patients affected by mas-
sive irreparable rotator cuff tears were treated with the implantation of InSpace Balloon®. Clinical evaluation 
(Constant Score and VAS), X-rays and MR imaging were performed preoperatively in all patients and 3, 6, 12 
and 24 months after surgery, dividing patients in different groups according to the time elapsed from surgery. 
Results: Constant Score increased from 39.89 to 62.33 points (p 0.0002) in the 6 months group and from 
41.66 to 65.38 points (p< 0.0001) in the 12 months group. ROM (Range of Movement) and ADL (Activity 
of Daily Living) significantly improved with the contemporary reduction of VAS and pain at 12 months and, 
furthermore, an increase of functional performance with reduction of pain was registered at 24 months. Con-
clusions: Our results supported the surgical procedure of the arthroscopic implantation of biodegradable sub-
acromial InSpace Balloon® for irreparable massive cuff tears in worker patients and with recreational activi-
ties’ demands in order to recover the shoulder function with a reduction of the pain. (www.actabiomedica.it)
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O r i g i n a l  a r t i c l e
Introduction
Rotator cuff tears (RCTs) are age-dependent 
common injuries affecting millions of people (1). Re-
pair of these lesions is performed safely with arthro-
scopic techniques and leads to proven clinical benefit. 
Large lesions are associated with poor results and fail-
ure (2). Regarding classifications, in literature there is 
a distinction between massive and irreparable rotator 
cuff tears (IRCTs) (3). Massive tears are considered 
those more than 5 cm, involving two or more tendons, 
while IRCTs are lesions that cannot be repaired back 
to the native footprint or that, once repaired, almost 
certainly lead to a structural failure (4). In clinical di-
agnosis of IRCTs, static anterosuperior subluxation 
and associated pseudoparalysis on anterior elevation 
are suggestive. At the imaging, superior migration of 
the humeral head with acromiohumeral interval less 
than 7 mm at x-rays and grade 3 and 4 fatty infiltra-
tion according to the Goutallier classification (5) at 
CT scans is observed.
Several surgical options are available for the treat-
ment of IRCT with the intent of reducing pain and 
improving functions. These options includes subacro-
mial decompression or debridement, partial tendon re-
pair, tendon transfer, muscle-tendon slide procedures, 
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the use of rotator cuff allograft and synthetic grafts, 
arthrodesis, hemiarthroplasty and reverse total shoul-
der arthroplasty (6-7).
One recent arthroscopic alternative is the implant 
of a biodegradable subacromial spacer, the InSpace 
balloon (OrthoSpace, Kfar Saba, Israel), initially de-
scribed by Savarese and Romeo (8), which permits 
better gliding restoring shoulder kinematics with low 
rate of complications (9). 
Our purpose was to confirm the good results de-




This retrospective study is a case series performed 
in single Institute. From February 2014 to October 
2015, 30 patients (17 females, 13 males; mean age 65.7 
years) affected by massive irreparable rotator cuff tears 
(IRCT) were treated with the implantation of InSpace 
Balloon®.
All patients were fully informed on the charac-
teristics of treatment and gave their written informed 
consent. 
The indication for surgery was made on clinical 
signs of IRCT and MR imaging (Goutallier 3-4) (5) in 
patients who has persistent pain for at least 6 months 
after the failure of conservative treatment. Exclusion 
criteria included shoulder osteoarthritis, glen humeral 
instability, prior shoulder surgery and shoulder infec-
tion.
Patients were divided into 4 different groups 
based on the follow up’s time: 8 patients were evalu-
ated at 3 months after surgery, 9 patients at 6 months, 
8 patients at 12 months, 5 patients at 24 months.
Surgical technique and postoperative management
The same surgeon completed all the procedures. 
A standard arrangement for arthroscopic rotator cuff 
repair was used with the patient in a beach-chair po-
sition. Standard arthroscopic portals were performed, 
with biceps tenotomy, sub acromial bursectomy and 
acromioplasty in all cases. Patients were under general 
anaesthesia and interscalene block. 
The preoperative instrumental diagnosis of irrep-
arable massive rotator cuff tears was confirmed during 
arthroscopy in all cases. We measured the subacro-
mial space using an arthroscopic probe (provided in 
the InSpace Balloon System® kit); then we selected 
the correct implant size choosing between small, me-
dium and large. We prepared the inflating system and 
filled syringe with 0.9% saline solution pre-heated to 
40 degrees Celsius. After Balloon inflation, we verified 
its stability through full ROM. After surgery patients 
wore a sling for one week and began full active assisted 
range of motion and early active ROM at low level; 
overhead activity was avoided for 6 weeks.
Outcome assessment
The same orthopaedic team performed pre- and 
post-operatively clinical evaluation. X-rays and MR 
imaging was performed preoperatively and, depend-
ing on groups, at 3, 6, 12 and 24 months after surgery. 
Clinical evaluation was conducted using the Constant 
Score (10) and pain was recorded with VAS. Subacro-
mial space was measured on standard AP X-rays (5) by 
the same senior radiologist.
Statistical analysis
Study data were analysed using SPSS program for 
Macintosh (20.0 version) and the differences of mean 
results were evaluated with Wilcoxon T test. P values 
<0.05 were considered statistically significant.
Results
Clinical preoperative values of Total Constant 
Score (TCS), pain, Range of Movement (ROM), 
strength in abduction with dynamometer, ADL (Ac-
tivity of daily living) and VAS showed no significative 
differences between groups (Table 1A).
Table 1B shows the mean results for each group 
of follow-up. We focused on temporary variation of 
values between preoperative and postoperative out-
comes at 3, 6, 12 and 24 months after surgery. 
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Clinical results
After 3 months we observed a statistically sig-
nificative improvement of Constant Total Score (from 
39.75 to 55.63 points) with positive results in pain, 
ADL and VAS, without any significative evidence.
Otherwise, we obtained a significative improve-
ment in pain reduction and function at 6 and 12 
months. After 6 months the mean TCS significantly 
improved from 39.89 to 62.33 points (p 0.0002) with a 
reduction of pain (from 4.44 to 9.44 points, p 0.0153), 
improvement of ADL (from 1.1. to 3.56 points, 
p 0.0001); VAS decreased from 6.45 to 3.67 points 
(p 0.0019). 
A further increase of values was observed after 
12 months, with a mean TCS of 65.38 points (p< 
0.0001), a reduction of pain (from 3.75 to 10.63 points, 
p 0.0032), an increase of ADL (from 1.75 to 3.5 
points, p 0.0074) and the statistical improvement of 
VAS (from 6.23 to 2.86 points, p 0.0001).
After 24 months we registered another slight 
increase of results: TCS increased to 66.8 points 
(p<0.0001), there was reduction of pain (score from 4 
to 12, p 0.00072), increase of ADL (from 1.6 to 3.6, 
p<0.046) and VAS (from 6.6 to 2.8, p 0.0019) (Fig. 1).
Radiographic results
The X-rays analysis showed that acromio-
humeral interval raised from 6.61 to 7.99 at 3 months 
(p<0.0001), from 6.63 to 8.16 at 6 months (p 0.0004), 
Table 1 
A
p value TCS PAIN ROM Strenght ADL VAS SAS
3 months 0,0001 0,0037 0,0002 0,2564 0,0037 0,0005 <0,0001
6 months 0,0002 0,0153 0,0001 0,3755 0,0001 0,0019 0,0004
12 months <0,0001 0,0032 <0,0001 0,0633 0,0074 0,0001 0,0067
24 months <0,0001 0,0072 <0,0001 0,0943 0,0462 0,0019 0,0007
B
  TCS Pain ROM Strenght ADL VAS SAS SIzE (cm) 
PRE 39,75 2,5 33 3,5 0,75 6,13 6,61  
PRE 39,89 4,44 30 4,3 1,1 6,45 6,63   
PRE 41,66 3,75 32,5 3,88 1,75 6,25 6,45  
PRE 41,8 4 32,4 3,8 1,6 6,6 6,67   
3 months 55,63 8,13 40,75 5 3 3,38 7,99 4x7 
6 months 62,33 9,44 43,56 5,67 3,56 3,67 8,16 2,5x7 
12 months 65,38 10,63 44,75 5,75 3,5 2,86 7,09 3x6,5 
24 months 66,8 12 45,6 6,2 3,6 2,8 7,94 - 
TCS: Total Costant Score; ROM: Range of motion; SAS: Subacromial space; VAS: Visual analogue scale for pain;
SIzE: balloon size measured by MRI; ADL: activity of dayly living
Figure 1. TCS: Total Costant Score; ROM: Range of motion; 
SAS: Subacromial space; VAS: Visual analogue scale for pain; 
SIzE: balloon size measured by MRI; ADL: activity of dayly 
living
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from 6.45 to 7.09 at 12 months (p 0.00067) and from 
6.67 to 7.94 at 24 months (p 0.0007). 
MRI results
We decided to complete the study with the MR 
description of spacer. At 3 months the implant was 
evident in subacromial space with a mean width of 4 
cm and a thickness of 7 mm (Fig. 2). The radiologist 
described effusion joint strata at 6 months, while the 
spacer appeared significantly reduced in volume at 12 
months (width decreased to 3 cm and thickness was 
reduced to 6.5 mm). At the end of follow-up the im-
plant was not recognizable, replaced by a layer of fi-
brosis with a mean width of 2 cm and a thickness of 4 
mm (Fig. 3).
Functional results
At 3 months we observed positive results in ROM 
(from 33 to 40,75 points, p 0.0002) and in strength 
(from 3.5 to 5 points). After 6 months the improve-
ment of ROM was from 30 to 43.56 points, p< 0.0001 
and strength increased from 4.3 to 5.67 points. More-
over a further development of ROM was registered 
at 12 months (from 32.5 to 44.75 points, p< 0.0001) 
with strength from 3.88 to 5.7 points. After 24 months 
there was a slight increase of ROM (from 32.4 to 45.6 
points, p< 0.0001) and strength (from 3.8 to 6.2)
Discussion
Based on our results, spacer improves functional 
outcomes and pain reduction, with a significant in-
crease of Constant Score values (p< 0.002 at 6 months) 
and VAS (p< 0.015 at 6 months, 2 points at 12 months, 
p< 0.038), the good outcomes continuing to be main-
tained at 24 months. 
Our results  are in line with Senekovic et al (9) 
that reported an increase of Total Constant Score from 
33.4 to 65.4 points on 20 patients treated with InS-
pace Balloon®, with an evident improvement of power 
at 18 months (p< 0.003) and of function at 3 years. 
Similar outcomes were obtained by Naggar et al (11). 
In a mean follow-up of 24 months good and excellent 
results were reported in 86% of patients, with pain re-
lief and a recovery often after six weeks. Furthermore 
he registered an increase of active and painless ROM. 
The Constant Score almost doubled and the improve-
ment continued up to 18 months after surgery. These 
authors support the advantages of subacromial spacer 
described by Szollosy et al in 2014 (12). 
Figure 2. MRI at 3 months follow up
Figure 3. MRI at 24 months follow up
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Analyzing X-ray and MR imaging, all patients 
presented before surgery an acromiohumeral distance 
less than 6 mm and grade lesion 3-4 according to 
Goutallier, while postoperative the space always was 
> 7 mm. The same measures were reported on Austral-
ian Safety and Efficacy Register of New International 
Procedures-Surgical in December 2014 end March 
2015 (13). However, to complete this data we ana-
lysed MR imaging in the postoperative period. From 
6 to 12 months the spacer was visible but progres-
sively smaller-sized, and contemporary inflammatory 
stratus absorption was obseved. Furthermore, we ob-
served that the degradation process started over 12 
months to be completed at 24 months, like Savarese 
et al argued in 2012 (8). These radiological data can 
support clinical trends observed in our study and they 
can complete results described by Senekovic and Nag-
gar (9-11).
In literature there are other different surgical op-
tions proposed to treat IRCT when no-operative solu-
tions have failed. 
Neviaser et al were the first that used the graft in-
terposition with good or excellent clinical results (14) 
but other authors criticized this procedure for the lack 
of pain relief and poor clinical outcomes (15). 
Rockwood and Kempf studied the outcomes of 
debridement with or without biceps tenotomy (16-
17); although they found good clinical results, a vari-
ety of studies showed no advantages in osteoarthritis 
progression (4). 
In 1993 Burkhart et al (18) introduced the partial 
repair of rotator cuff with the concept of “suspension 
bridge”. This option obtained improvements in active 
elevation (from 59.6° to 150.4°) and in the UCLA 
Score (from 9.8 to 27.6 points). Afterwards Duralde 
et al reported significant increase in ASES Index, pain 
and activation (19).
Another technique is the “interval slide” proposed 
by Tauro and Lo (20-21). Nevertheless Kim el al 
found 91% of retear rate and patients who underwent 
this operation did not showed significative reduction 
of pain or improve of functional outcomes (22). 
The arthroscopic superior capsule reconstruction 
recently described by Mihata (23) was preferred to the 
graft that can develop an interposition to the torn ten-
don with a consequent impingement. 
Unfortunately all these studies were conducted on 
small cohort of patients without control group.
Further researches are necessaries to provide de-
finitive guidelines in the treatment of IRCT, a chal-
lenging condition that reduces life performance of 
adult with working and recreational demands.
Despite lack of strong evidences about the supe-
riority of one technique, the implantation of a biode-
gradable spacer (InSpace technology) could be the last 
and functional solution (24-25).
Conclusions
This study shows that subacromial biodegradable 
spacer is a minimally invasive procedure with good 
mid term clinical and instrumental results in irrepa-
rable rotator cuff tears. The improvement of Constant 
Score, VAS and shoulder function allows to assert that 
InSpace Balloon® can be considered as a valid surgical 
option in patients with irreparable rotator cuff tears es-
pecially in order to postpone more invasive procedures. 
Ethical approval: All procedures performed in studies involv-
ing human participants were in accordance with the ethical 
standards of the institutional and/or national research commit-
tee and with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards.
References
1.  Tonino PM, Gerber C, Itoi E, Porcellini G, Sonnabend D, 
Walch G. Complex shoulder disorders: evaluation and treat-
ment. J Am Acad Othop Surg 2009; 17: 125-36.
2.  Flurin PH, Landreau P, Gregory T, et al. Arthroscopic repair 
of full-thickness cuff tears: A multicentric retrospective study 
of 576 cases with anatomical assessment. Rev Chir Orthop 
Reparatrice Appar Mot 2005; 91: 31-42 [in French].
3.  Omid R, Lee B. Tendon transfers for irreparable rotator cuff 
tears. J Am Acad Orthop Surg 2013; 21: 492-501.
4.  Gerber C, Wirth SH, Farshad M. Treatment options for 
massive rotator cuff tears. J Shoulder Elbow Surg 2011; 20: 
S20-S29.
5.  Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC. 
Fatty muscle degeneration in cuff ruptures: pre- and postop-
erative evaluation by CT scan. Clin Orthop Relat Res 1994; 
304: 78-83.
6.  Moser M, Jablonski MV, Horodyski M, Wright TW. Func-
tional outcome of surgically treated massive rotator cuff tears: 
M. Ricci, E. Vecchini, E. Bonfante, et al.80
   A comparison of complete repair, and debridment. Ortho-
pedics 2007; 30: 479-82.
7  .  Goutallier D, Le Guilloux P, Postel JM, Radier C, Ber-
nageau J, zilber S. Acromio humeral distance less than six 
millimeter: its meaning in full-thickness rotator cuff tear. 
Orthopaedics & Traumatology: Surgery & Research 2011; 
97: 246-51.
  8.  Savarese E, Romeo R. New solution for massive, irreparable 
rotator cuff tears: the subacromial “biodegradable spacer”. 
Arthrosc Tech 2012; 1: e69-e74.
  9.  Senekovic V, Poberaj B, Kovacic L, Mikek M, Adar E, De-
kel A. Prospective clinical study of a novel biodegradable 
sub-acromial spacer in treatment of massive irreparable ro-
tator cuff tears. Eur J Orthop Surg Traumatol doi 10.1007/
s00590-012-0981-4.
10.  Constant CR, Murley AH. A clinical method of functional 
assessment of the shoulder. Clin Othop and Relat Res 1987; 
214: 160-4.
11.  Naggar L. The balloon, a new revolutionary technique for 
massive irreparable rotator cuff tears: preliminary results at 
1 year follow-up, after balloon degradation. Swiss Medical 
Weekly [serial on the Internet] 2013; Supp. 198: 143.
12.  Szollosy G, Rosso C, Fogerty S, Petkin K, Lafosse L. Subac-
romial spacer placement for protection of rotator cuff repair. 
Arthrosc Tech 2014; 5: e605-e609.
13.  Australian Safety and Efficacy Register of New Interven-
tional Procedures-Surgical (ASERNIP-S) March 2015. 
Available from: http://www.health.qld.gov.au/healthpact
14.  Neviaser JS, Neviaser RJ, Neviaser TJ. The repair of chronic 
massive ruptures of the rotator cuff of the shoulder by use 
of a freeze-dried rotator cuff. J Bone Joint Surg Am 1978; 
60: 681-4.
15.  Nasca RJ. The use of freeze-dried allograft in the manage-
ment of global rotator cuff tears. Clin Orthop Relat Res 
1988; 228: 218-26.
16.  Rockwood CA, Williams GR, Burkhead Wz. Debride-
ment of degenerative, irreparable lesions of the rotator cuff. 
J Bone Joint Surg Am 1995; 77: 857-66.
17.  Kempf JF, Gleyze P, Bonnomet F, WalchG, Mole D, Frank 
A, Beaufils P, Levigne C, Rio B, Jaffe A. A multicenter 
study of 210 rotator cuff tears treated by arthroscopic acro-
mioplasty. Arthroscopy 1999; 15: 56-66.
18.  Burkhart SS, Esch JC, Jolson RS. The rotator crescent and 
rotator cable: an anatomic description of the shoulder’s “sus-
pension bridge”. Arthroscopy 1993; 9: 611-6.
19.  Duralde XA, Bair B. Massive rotator cuff tears: the result 
of partial rotator cuff repair. J Shoulder Elbow Surg 2005; 
14: 121-7.
20.  Tauro JC. Arthroscopic “interval slide” in the repair of large 
rotator cuff tears. Arthroscopy 1999; 15: 527-30.
21.  Lo IK, Burkhart SS. Arthroscopic repair of massive, con-
tracted, immobile rotator cuff tears using single and double 
interval slides: technique and preliminary results. Arthros-
copy 2004; 20: 22-3.
22.  Kim SJ, Kim SH, Lee SK, Seo JW, Chun YM. Arthroscopic 
repair of massive contracted rotator cuff tears: aggressive re-
lease with anterior and posterior interval slides do not im-
prove cuff healing and integrity. J Bone Joint Surg Am 2013; 
95: 1482-8.
23.  Mihata T, Lee TQ, Watanabe C, Fukunishi K, Ohue M, 
Tsujimura T, Kinoshita M. Clinical results of arthroscopic 
superior capsule reconstruction for irreparable rotator cuff 
tears. Arthroscopy 2013; 29: 459-70.
24.  Sartoretti C, Sartoretti-Schefer S, duff C, Buchmann P. An-
gioplasty balloon catheters used for distraction of the ankle 
joint. Arthroscopy 1996;12: 82-6.
25.  Kilinc AS, Ebrahimzadeh MH, Lafosse L. Subacromial 
internal spacer for rotator cuff tendon repair: “The balloon 
technique”. Arthoscopy 2009; 25: 921-4.
Received: 25 June 2017
Accepetd: 16 July 2017
Correspondance:
Eugenio Vecchini
Department of Orthopaedics and Trauma Surgery, 
University of Verona, Azienda Ospedaliera Universitaria
Integrata di Verona (Italy)
Tel. +39 0458123276 - Fax +39 0458123578
E-mail: vecchinie@gmail.com
